petri_dish_and_pippet_139x88Lab 21 supports clinical laboratories, healthcare providers and large pharmaceutical companies in the biotechnology industry with its technically advanced testing services and products.

Products range from cancer typing, tropisms y genotype, EGFR mutation tests, syphilis, malaria, CMV, blood grouping, tubercolosis, clostridium antitoxins and diabetes.  It supplies to over 115 countries worldwide.

img_icxtrc3_176x117Lab 21 has focused on a buy-and-build strategy and has acquired and fully integrated a number of clinical diagnostic laboratories such as Newmarket Labs Ltd, Biotech Ltd, Plasmatech Ltd and Microgen Ltd and is predicting revenues will rise to more than $200m within the next few years.